EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Plaque‐Targeted Delivery of Fluoride‐Free MXene Nanozyme for Alleviating Atherosclerosis via Sonocatalytic Therapy

Qianqian Bai iD, Xinyue Lao, Sin-Yi Pang iD, Yifei Zhao, Yuan Liu, Xiao Yu Tian, Jianhua Hao iD

Advanced Materials · 2025-12 · 37 (48)

DOI: 10.1002/adma.202420189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 07.07.2025. Verfasst von Qianqian Bai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Physics, The Hong Kong Polytechnic University, Hong Kong, 999077, P. R. China. Hauptthemen laut MEDLINE: Atherosclerosis, Plaque, Atherosclerotic. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: PolyU Grants, Hong Kong Polytechnic University, Research Grants Council of the Hong Kong Special Administration Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is an oxidative stress‐induced chronic inflammatory condition underpinning the progression of cardiovascular diseases (CVDs), ultimately resulting in leading mortality rate globally. Ultrasound (US)‐triggered catalysis offers localized treatment for deep‐seated plaques effectively and safely, with demand for targeted delivery and anti‐inflammatory properties of sonosensitizers. 2D MXene‐based nanomedicine is garnering attention because of their intriguing catalytic properties of scavenging excessive reactive oxygen species (ROS), yet MXene‐assisted sonocatalytic therapy (SCT) for treating CVDs remains scarce. Here, this study reports a dual enzyme‐mimicking and US‐responsive MXene termed Nb 2 C‐Pt@HA‐PEG for alleviating atherosclerosis. US irradiation enhances the capability of Nb 2 C‐Pt@HA‐PEG nanozymes in eliminating broad‐spectrum ROS and resolving vascular inflammation. Besides, actively targeting lesional macrophages improves their systemic delivery to plaque and further boosts anti‐atherosclerotic efficacy, contributing to ≈30% plaque size reduction and a more stabilized plaque phenotype. Notably, etching without hydrofluoric acid renders this nanozyme highly biocompatible. In long‐term biosafety studies, Nb 2 C‐Pt@HA‐PEG is pronouncedly cleared from major organs and no severe changes of liver and kidney functions are observed. Consequently, this work demonstrates that Nb 2 C‐Pt@HA‐PEG‐mediated SCT effectively ameliorates advanced atherosclerosis without inducing severe cytotoxicity, offering promising translational potential of MXene‐based nanomedicine. Besides, it broadens application prospects of MXenes to the biomedical field of treating CVDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisPlaque, AtheroscleroticAnimalsMiceCatalysisReactive Oxygen SpeciesHumansRAW 264.7 CellsUltrasonic WavesMice, Inbred C57BLPolyethylene GlycolsMaleNitritesTransition Elements

Stichwörter der Autor:innen

2D materialscardiovascular diseasesfluoride‐free MXenenanomedicinesonocatalytic therapy

Substanzen

Reactive Oxygen SpeciesPolyethylene GlycolsMXeneNitritesTransition Elements

Autor:innen und Institutionen

  • Department of Applied Physics, The Hong Kong Polytechnic University, Hong Kong, 999077, P. R. China.
  • School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, 999077, P. R. China.
  • Department of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, 999077, P. R. China.
  • Research Centre for Nanoscience and Nanotechnology, The Hong Kong Polytechnic University, Hong Kong, 999077, P. R. China.

ORCID-Profile: Qianqian Bai, Sin-Yi Pang, Jianhua Hao

Förderung

  • PolyU Grants
  • Hong Kong Polytechnic University
  • Research Grants Council of the Hong Kong Special Administration Region

Zitieren

APA

Bai, Q., Lao, X., Pang, S. Y., Zhao, Y., Liu, Y., Tian, X. Y., & Hao, J. (2025). Plaque‐Targeted Delivery of Fluoride‐Free MXene Nanozyme for Alleviating Atherosclerosis via Sonocatalytic Therapy. Advanced Materials, 37(48). https://doi.org/10.1002/adma.202420189

Vancouver

Bai Q, Lao X, Pang SY, Zhao Y, Liu Y, Tian XY, et al. Plaque‐Targeted Delivery of Fluoride‐Free MXene Nanozyme for Alleviating Atherosclerosis via Sonocatalytic Therapy. Advanced Materials. 2025;37(48). doi:10.1002/adma.202420189

BibTeX
@article{Bai2025,
  author = {Bai, Qianqian and Lao, Xinyue and Pang, Sin-Yi and Zhao, Yifei and Liu, Yuan and Tian, Xiao Yu and Hao, Jianhua},
  title = {Plaque‐Targeted Delivery of Fluoride‐Free MXene Nanozyme for Alleviating Atherosclerosis via Sonocatalytic Therapy},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {48},
  doi = {10.1002/adma.202420189}
}
Kostenlos starten →